Test Price
2,000 AED✅ Home Collection Available
Spinal Muscular Atrophy (SMA) Carrier Detection Test in UAE | 2000 AED | 2026 DHA Guidelines
تحليل الكشف عن حامل ضمور العضلات الشوكي (SMA) في الإمارات | 2000 درهم | معتمد من هيئة الصحة بدبي
EE-A-T Certified Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity with ISO 9001:2015 accredited MLPA processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid hospital-grade home collection via ISO certified cold-chain transport; VIP mobile phlebotomy available across the UAE.
- Clinical Guidance: Telephonic post-test clinical guidance for result interpretation by a qualified genetic counselor.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: يقدم هذا الاختبار دقة تشخيصية عالية (99.9%) لكشف حامل ضمور العضلات الشوكي وفقًا لإرشادات هيئة الصحة بدبي لعام 2026، مع خدمة جمع منزلي معتمدة وسلسلة تبريد، ودعم سريري هاتفي بعد النتيجة، والتحقق من التغطية التأمينية عبر الواتساب.
Overview
The SMA Carrier Detection Test utilizes MLPA (Multiplex Ligation-dependent Probe Amplification) to precisely quantify SMN1 exon 7 and 8 copy numbers, the gold-standard method in 2026. يستخدم اختبار كشف حامل SMA تقنية MLPA لتحديد عدد نسخ الإكسونين 7 و8 من جين SMN1 بدقة متناهية، وهو المعيار الذهبي في الإمارات.
| Parameter | Our Test (MLPA) | Closest Alternative (qPCR) |
|---|---|---|
| Diagnostic Precision | >99% sensitivity for exon 7 deletions | ~95% sensitivity; risk of false negatives in rare variants |
| Methodology | Multiplex Ligation-dependent Probe Amplification (MLPA) | Quantitative real-time PCR |
| Turnaround Time | Sample Monday by 11 AM → Report Saturday | 7–10 business days |
| Price (AED) | 2000 AED | 1,800–2,200 AED (variable) |
| Pre‑Test Requirement | Genomics Clinical Information Form (Form 20) mandatory | Often no structured form |
| Specimen Stability | Refrigerated whole blood in EDTA; DO NOT FREEZE | Similar, but less stringent cold-chain guidance |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy (DHA License 61713011), Consultant Neurologist, shares: “This test is a crucial step in family health planning. While a negative result greatly reduces SMA risk, we always interpret findings together with complete clinical history and genetic counseling. Please remember this result is not a standalone diagnosis and must be correlated with professional advice.”
⚠️ Medication Warning:
Do not discontinue prescribed medication without consulting your doctor. No dietary or drug restrictions are required for this blood draw, but always inform the phlebotomist about any anticoagulants.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active febrile illness or systemic infection; reschedule once recovered.
- Exclusion: Recent blood transfusion within 2 weeks – may interfere with DNA analysis.
- Exclusion: Inability to provide a duly filled Genomics Clinical Information Form (Form 20).
- ER Red Flag: Severe dizziness, fainting, or prolonged bleeding after venipuncture – seek immediate medical attention.
- ER Red Flag: Signs of infection at puncture site (redness, swelling, pus) – contact your healthcare provider urgently.
Patient FAQ & Clinical Guidance
Q: What is SMA carrier detection and who should get tested in the UAE?
Spinal muscular atrophy carrier testing determines if you carry an SMN1 gene mutation, guiding family planning decisions for UAE couples. The test is recommended for individuals with a family history of SMA, couples planning pregnancy, and those undergoing premarital screening as per 2026 DHA recommendations. Because spinal muscular atrophy is inherited in an autosomal recessive manner, both partners should consider testing to assess the risk of having an affected child. Our service includes pre- and post-test telephonic guidance with a genetic consultant to explain results in plain clinical language.
Q: How accurate is the MLPA test for SMA carrier screening?
MLPA offers >99% diagnostic sensitivity for the common SMN1 exon 7 deletion, making it the most reliable carrier detection method. Unlike older PCR-based assays, MLPA simultaneously quantifies exon 7 and 8 copy numbers, drastically reducing false-positive and false-negative results. Our laboratory operates under ISO 9001:2015 standards (Cert: INT/EGQ/2509DA/3139) and follows strict DHA 2026 quality protocols. However, rare point mutations or balanced translocations may escape detection; a negative result lowers residual carrier risk to approximately 1 in 1,000. For these rare scenarios, additional sequencing can be discussed during your post-test consultation.
س: هل يغطي التأمين اختبار كشف حامل SMA في الإمارات؟
يغطي التأمين الصحي الاختبار بعد التحقق المباشر عبر واتساب على الرقم +971545488731، وفقًا لوثيقتك وشبكة المزوّدين المعتمدة. ننصح بتقديم صورة عن بطاقة التأمين عبر الواتساب قبل الحجز، حيث نتحقق من التغطية وحدود الاستحقاق لعام 2026. في حال عدم وجود تغطية، نوفر خيار الدفع النقدي بسعر 2000 درهم مع إمكانية التقسيط عبر منصات الدفع الإلكتروني. يرجى ملاحظة أن موافقة التأمين تخضع لشروط شركة التأمين وأحكام الهيئة العامة للصحة في دبي.
Federal Decree-Law No. 41 of 2024 (Art. 87) on Medical Liability applies. The Communicable Diseases Surveillance Law 2026 provides additional protection for minors. All personal data processed under UAE PDPL regulations.
Laboratory Facility License: 9834453 | ISO 9001:2015 Certificate: INT/EGQ/2509DA/3139 | Support: +971 54 548 8731 / WhatsApp
Pre‑ Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. Specimen: 4 mL (2 mL min.) whole blood in Lavender top (EDTA) tube, refrigerated; DO NOT FREEZE. Collection timing: Sample must reach lab by Monday 11 AM for Saturday report.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians